Literature DB >> 17412486

Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound.

Denise A B Smith1, Tyrone M Porter, Janet Martinez, Shaoling Huang, Robert C MacDonald, David D McPherson, Christy K Holland.   

Abstract

Echogenic liposomes (ELIP) are submicron-sized phospholipid vesicles that contain both gas and fluid. With antibody conjugation and drug incorporation, these liposomes can be used as novel targeted diagnostic and therapeutic ultrasound contrast agents. The utility of liposomes for contrast depends upon their stability in an acoustic field, whereas the use of liposomes for drug delivery requires the liberation of encapsulated gas and drug payload at the desired treatment site. The objective of this study was twofold: (1) to characterize the stability of liposome echogenicity after reconstitution and (2) to quantitate the acoustic destruction thresholds of liposomes as a function of peak rarefactional pressure (P(r)), pulse duration (PD) and pulse repetition frequency (PRF). The liposomes were insonified in an anechoic sample chamber using a Philips HDI 5000 diagnostic ultrasound scanner with a L12-5 linear array. Liposome stability was evaluated with 6.9-MHz fundamental and 4.5-MHz harmonic B-mode pulses at various P(r) at a fixed PRF. Liposome destruction thresholds were determined using 6.0-MHz Doppler pulses, by varying the PD with a fixed PRF of 1.25 kHz and by varying the PRF with a fixed PD of 3.33 micros. Videos or freeze-captured images were acquired during each insonation experiment and analyzed for echogenicity in a fixed region of interest as a function of time. An initial increase in echogenicity was observed for fundamental and harmonic B-mode imaging pulses. The threshold for acoustically driven diffusion of gas out of the liposomes using 6.0-MHz Doppler pulses was weakly dependent upon PRF and PD. The rapid fragmentation thresholds, however, were highly dependent upon PRF and PD. The quantification of acoustic destruction thresholds of ELIP is an important first step in their development as diagnostic and drug delivery agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412486     DOI: 10.1016/j.ultrasmedbio.2006.11.017

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  36 in total

1.  In vivo therapeutic gas delivery for neuroprotection with echogenic liposomes.

Authors:  George L Britton; Hyunggun Kim; Patrick H Kee; Jaroslaw Aronowski; Christy K Holland; David D McPherson; Shao-Ling Huang
Journal:  Circulation       Date:  2010-10-04       Impact factor: 29.690

2.  Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.

Authors:  Natalya Rapoport; Kweon-Ho Nam; Roohi Gupta; Zhongao Gao; Praveena Mohan; Allison Payne; Nick Todd; Xin Liu; Taeho Kim; Jill Shea; Courtney Scaife; Dennis L Parker; Eun-Kee Jeong; Anne M Kennedy
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

3.  Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter.

Authors:  Jonathan A Kopechek; Kevin J Haworth; Jason L Raymond; T Douglas Mast; Stephen R Perrin; Melvin E Klegerman; Shaoling Huang; Tyrone M Porter; David D McPherson; Christy K Holland
Journal:  J Acoust Soc Am       Date:  2011-11       Impact factor: 1.840

4.  Passive imaging with pulsed ultrasound insonations.

Authors:  Kevin J Haworth; T Douglas Mast; Kirthi Radhakrishnan; Mark T Burgess; Jonathan A Kopechek; Shao-Ling Huang; David D McPherson; Christy K Holland
Journal:  J Acoust Soc Am       Date:  2012-07       Impact factor: 1.840

Review 5.  In vitro methods to study bubble-cell interactions: Fundamentals and therapeutic applications.

Authors:  Guillaume Lajoinie; Ine De Cock; Constantin C Coussios; Ine Lentacker; Séverine Le Gac; Eleanor Stride; Michel Versluis
Journal:  Biomicrofluidics       Date:  2016-01-28       Impact factor: 2.800

6.  Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature.

Authors:  Kyle D Buchanan; Shaoling Huang; Hyunggun Kim; Robert C Macdonald; David D McPherson
Journal:  J Pharm Sci       Date:  2008-06       Impact factor: 3.534

Review 7.  Cardiovascular therapeutic uses of targeted ultrasound contrast agents.

Authors:  Susan T Laing; David D McPherson
Journal:  Cardiovasc Res       Date:  2009-07-06       Impact factor: 10.787

8.  Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.

Authors:  Shao-Ling Huang; Patrick H Kee; Hyunggun Kim; Melanie R Moody; Stephen M Chrzanowski; Robert C Macdonald; David D McPherson
Journal:  J Am Coll Cardiol       Date:  2009-08-11       Impact factor: 24.094

9.  Ultrasound-triggered microbubble destruction in combination with cationic lipid microbubbles enhances gene delivery.

Authors:  Li Zhang; Yingying Liu; Guangya Xiang; Qing Lv; Gui Huang; Yali Yang; Yanrong Zhang; Yue Song; Huan Zhou; Mingxing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

10.  Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes.

Authors:  Denise A B Smith; Sampada S Vaidya; Jonathan A Kopechek; Shao-Ling Huang; Melvin E Klegerman; David D McPherson; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2010-01       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.